Crucell calls shareholder meeting to discuss J&J offer

Crucell NV has scheduled an informal meeting of shareholders for 10 December 2010 to discuss Johnson & Johnson’s offer to acquire all of the outstanding shares in the company that it does not already own, in a bid valued at about  €1.75 billion.